GSK Makes New Adult Immunization Push, Seeks Reimbursement Changes Following RSV Approvals

 
• By Sarah Karlin-Smith

From ACIP to Part D to data transparency, GSK has several policy asks as it prepares to launch its new RSV vaccine for older adults. The Pink Sheet spoke with GSK’s vaccine policy lead about the firm’s new data platform and the worrisome US vaccination trends following the Covid pandemic.

doctor and patient
GSK wants seniors to be able to get Medicare Part D vaccines in physician offices. • Source: Shutterstock

More from Vaccines

More from Pink Sheet